Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Non-Current Debt (2016 - 2025)

Bio-Techne has reported Non-Current Debt over the past 12 years, most recently at $260.0 million for Q4 2025.

  • Quarterly results put Non-Current Debt at $260.0 million for Q4 2025, down 13.33% from a year ago — trailing twelve months through Dec 2025 was $260.0 million (down 13.33% YoY), and the annual figure for FY2025 was $346.0 million, up 8.46%.
  • Non-Current Debt for Q4 2025 was $260.0 million at Bio-Techne, down from $300.0 million in the prior quarter.
  • Over the last five years, Non-Current Debt for TECH hit a ceiling of $447.0 million in Q4 2023 and a floor of $200.0 million in Q4 2022.
  • Median Non-Current Debt over the past 5 years was $300.0 million (2024), compared with a mean of $309.7 million.
  • Biggest five-year swings in Non-Current Debt: plummeted 50.18% in 2021 and later skyrocketed 123.5% in 2023.
  • Bio-Techne's Non-Current Debt stood at $269.6 million in 2021, then fell by 25.82% to $200.0 million in 2022, then soared by 123.5% to $447.0 million in 2023, then crashed by 32.89% to $300.0 million in 2024, then dropped by 13.33% to $260.0 million in 2025.
  • The last three reported values for Non-Current Debt were $260.0 million (Q4 2025), $300.0 million (Q3 2025), and $346.0 million (Q2 2025) per Business Quant data.